Alnylam Pharmaceuticals, Inc.

Central Pacific Bank - Trust Division ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/7/2026

Shares

2,413

Value ($000)

960

Weight

0.1%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/7/2026	960	0.1%	2,413	12/31/2025
2025 Q3	10/2/2025	1,202	0.1%	2,635	9/30/2025
2025 Q2	7/2/2025	984	0.1%	3,018	6/30/2025